Industry

Aural Analytics’ Speech Vitals technology delivers clinical-grade speech analytics PHOENIX–(BUSINESS WIRE)–#AuralAnalytics–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today it was awarded a $1.4 million grant from the National Institutes of Health. The grant supports Aural Analytics’ development of a tool speech-language pathologists can use to improve their clinical workflow. “The timing of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fractional Flow Reserve Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its News Release dated June 30, 2022. The private placement is being offered to accredited investors to raise up to $4 million … [Read more…]

SG Blocks and Clarity Lab Solutions joint venture, Clarity Mobile Venture, received an extension for COVID-19 testing at its Los Angeles International Airport location. JACKSONVILLE, Fla.–(BUSINESS WIRE)–SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading developer, designer, and fabricator of modular structures, announced today that Clarity Mobile Venture, a partnership with Clarity … [Read more…]

This updated version of the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform has added features and tools for neural circuit insights including peri-event analysis. MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#FENS–Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is launching the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform to … [Read more…]

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2022 financial results on Wednesday, Aug. 3, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at http://ir.horizontherapeutics.com. Please connect … [Read more…]

WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics, Inc., a biopharmaceutical company leading a renaissance in the discovery and development of small molecule medicines by utilizing structural biology and a proprietary computational platform, today announced the promotion of Daniel Koerwer from Chief Business Officer to Chief Operating Officer. In this new role, in addition to corporate and … [Read more…]

— Company shares proprietary and scalable approach using human derived organoids for preclinical pharmacodynamic (PD) assessment of drugs targeting podocyte cells — — Recent preliminary data from Phase 2 study of GFB-887 in focal segmental glomerular disease (FSGS) further validate feasibility and value of using transplanted human organoids in preclinical PD studies — CAMBRIDGE, Mass.–(BUSINESS … [Read more…]

TORONTO–(BUSINESS WIRE)–LifeWorks Inc. (TSX: LWRK) will announce its 2022 second quarter results after the market close on Thursday, August 11, 2022. About LifeWorks LifeWorks is a world leader in providing digital and in-person solutions that support the total wellbeing of individuals – mental, physical, financial and social. As the trusted leader in mental health and … [Read more…]

LITTLETON, Mass.–(BUSINESS WIRE)–#CancerTreatment–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the first patient was treated at the David C. Pratt Cancer Center at Mercy Hospital St. Louis on July 5th with the MEVION S250i Proton Therapy System®. The new Mercy Proton … [Read more…]